These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1054 related articles for article (PubMed ID: 33618678)
1. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors. Yin T; Li Y; Ying Y; Luo Z BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678 [TBL] [Abstract][Full Text] [Related]
2. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Bajgain KT; Badal S; Bajgain BB; Santana MJ Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. Dorjee K; Kim H; Bonomo E; Dolma R PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825 [TBL] [Abstract][Full Text] [Related]
6. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716 [TBL] [Abstract][Full Text] [Related]
7. Features of severe COVID-19: A systematic review and meta-analysis. Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457 [TBL] [Abstract][Full Text] [Related]
8. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients. Shin EK; Choi HY; Hayes N Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700 [TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Qiu P; Zhou Y; Wang F; Wang H; Zhang M; Pan X; Zhao Q; Liu J Aging Clin Exp Res; 2020 Sep; 32(9):1869-1878. PubMed ID: 32734576 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis. Zhao J; Li X; Gao Y; Huang W Int J Med Sci; 2020; 17(12):1744-1750. PubMed ID: 32714077 [TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD). He Y; Xie M; Zhao J; Liu X Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943 [TBL] [Abstract][Full Text] [Related]
12. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis. Honardoost M; Janani L; Aghili R; Emami Z; Khamseh ME Cerebrovasc Dis; 2021; 50(2):132-140. PubMed ID: 33530081 [TBL] [Abstract][Full Text] [Related]
13. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. Ge E; Li Y; Wu S; Candido E; Wei X PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047 [TBL] [Abstract][Full Text] [Related]
14. Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis. Cheng S; Zhao Y; Wang F; Chen Y; Kaminga AC; Xu H Medicine (Baltimore); 2021 Mar; 100(12):e24971. PubMed ID: 33761654 [TBL] [Abstract][Full Text] [Related]
15. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico. Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370 [TBL] [Abstract][Full Text] [Related]
17. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak. Wang Z; Wang Z BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706 [TBL] [Abstract][Full Text] [Related]
18. Population-based Estimates for High Risk of Severe COVID-19 Disease due to Age and Underlying Health Conditions. Laires PA; Nunes C Acta Med Port; 2020 Nov; 33(11):720-725. PubMed ID: 32707029 [TBL] [Abstract][Full Text] [Related]
19. The Centrality of Obesity in the Course of Severe COVID-19. Liu D; Zhang T; Wang Y; Xia L Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study. Fathi M; Vakili K; Sayehmiri F; Mohamadkhani A; Hajiesmaeili M; Rezaei-Tavirani M; Eilami O PLoS One; 2021; 16(2):e0246190. PubMed ID: 33592019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]